| References |
Top |
| REF 1 |
Role of PML and PML-RARalpha in Mad-mediated transcriptional repression. Mol Cell. 2001 Jun;7(6):1233-43.
|
| REF 2 |
MBD3, a component of the NuRD complex, facilitates chromatin alteration and deposition of epigenetic marks. Mol Cell Biol. 2008 Oct;28(19):5912-23.
|
| REF 3 |
Functional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancer. PLoS One. 2010 Jul 2;5(7):e11418.
|
| REF 4 |
PML/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia. Cancer Cell. 2010 Feb 17;17(2):186-97.
|
| REF 5 |
BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction. Oncogene. 2013 Jun 27;32(26):3156-64.
|
| REF 6 |
The function of PML in p53-dependent apoptosis. Nat Cell Biol. 2000 Oct;2(10):730-6.
|
| REF 7 |
Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells. Mol Cell Biol. 2008 Feb;28(3):997-1006.
|
| REF 8 |
PML-nuclear bodies are involved in cellular serum response. Genes Cells. 2003 Mar;8(3):275-86.
|
| REF 9 |
Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein. Cancer Cell. 2010 Sep 14;18(3):258-67.
|
| REF 10 |
Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies. J Virol. 2010 Nov;84(21):11113-23.
|
| REF 11 |
The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage. Blood. 2005 May 1;105(9):3686-90.
|
| REF 12 |
PML interacts with Myc, and Myc target gene expression is altered in PML-null fibroblasts. Oncogene. 2005 Mar 24;24(13):2195-203.
|
| REF 13 |
Control of nuclear HIPK2 localization and function by a SUMO interaction motif. Biochim Biophys Acta. 2011 Feb;1813(2):283-97.
|
